The effects of Staphylococcus aureus leukotoxins on the host: Cell lysis and beyond

Current Opinion in Microbiology

Volumn 16, Issue 1, 2013, Pages 63-69

  Yoong, Pauline ^a   Torres, Victor J ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA HEMOLYSIN; HEMOLYSIN; LEUKOTOXIN; LEUKOTOXIN AB; LEUKOTOXIN ED; PANTON VALENTINE LEUKOCIDIN; UNCLASSIFIED DRUG;

BACTEREMIA; BACTERIAL ARTHRITIS; CELL PHAGOCYTOSIS; CHANNEL GATING; CYTOLYSIS; CYTOTOXICITY; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNITY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PATHOGENESIS; PNEUMONIA; PROTEIN SUBUNIT; REVIEW; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS;

ANIMALS; EXOTOXINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; LEUKOCYTES; MODELS, BIOLOGICAL; MODELS, MOLECULAR; STAPHYLOCOCCUS AUREUS; VIRULENCE FACTORS;

STAPHYLOCOCCUS AUREUS;

EID: 84875804760     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2013.01.012     Document Type: Review

References (50)

1. Fridkin S.K., Hageman J.C., Morrison M., Sanza L.T., Como-Sabetti K., Jernigan J.A., Harriman K., Harrison L.H., Lynfield R., Farley M.M. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005, 352:1436-1444.
2. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., Johnson S.K., Vandenesch F., Fridkin S., O'Boyle C., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
3. Herold B.C., Immergluck L.C., Maranan M.C., Lauderdale D.S., Gaskin R.E., Boyle-Vavra S., Leitch C.D., Daum R.S. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998, 279:593-598.
4. Otto M. Basis of virulence in community-associated methicillin-resistant Staphylococcus aureus. Annu Rev Microbiol 2010, 64:143-162.
5. Bartlett A.H., Hulten K.G. Staphylococcus aureus pathogenesis: secretion systems, adhesins, and invasins. Pediatr Infect Dis J 2010, 29:860-861.
6. Aman M.J., Karauzum H., Bowden M.G., Nguyen T.L. Structural model of the pre-pore ring-like structure of Panton-Valentine leukocidin: providing dimensionality to biophysical and mutational data. J Biomol Struct Dyn 2010, 28:1-12.
7. Yamashita K., Kawai Y., Tanaka Y., Hirano N., Kaneko J., Tomita N., Ohta M., Kamio Y., Yao M., Tanaka I. Crystal structure of the octameric pore of staphylococcal gamma-hemolysin reveals the beta-barrel pore formation mechanism by two components. Proc Natl Acad Sci USA 2011, 108:17314-17319.
8. Finck-Barbancon V., Prevost G., Piemont Y. Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol 1991, 142:75-85.
9. Colin D.A., Mazurier I., Sire S., Finck-Barbancon V. Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect Immun 1994, 62:3184-3188.
10. Kaneko J., Ozawa T., Tomita T., Kamio Y. Sequential binding of Staphylococcal gamma-hemolysin to human erythrocytes and complex formation of the hemolysin on the cell surface. Biosci Biotechnol Biochem 1997, 61:846-851.
11. Meyer F., Girardot R., Piemont Y., Prevost G., Colin D.A. Analysis of the specificity of Panton-Valentine leucocidin and gamma-hemolysin F component binding. Infect Immun 2009, 77:266-273.
12. Kaneko J., Kamio Y. Bacterial two-component and hetero-heptameric pore-forming cytolytic toxins: structures, pore-forming mechanism, and organization of the genes. Biosci Biotechnol Biochem 2004, 68:981-1003.
13. Prevost G., Cribier B., Couppie P., Petiau P., Supersac G., Finck-Barbancon V., Monteil H., Piemont Y. Panton-Valentine leucocidin and gamma-hemolysin from Staphylococcus aureus ATCC 49775 are encoded by distinct genetic loci and have different biological activities. Infect Immun 1995, 63:4121-4129.
14. Gravet A., Colin D.A., Keller D., Girardot R., Monteil H., Prevost G. Characterization of a novel structural member, LukE-LukD, of the bi-component staphylococcal leucotoxins family. FEBS Lett 1998, 436:202-208.
15. Gauduchon V., Werner S., Prevost G., Monteil H., Colin D.A. Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect Immun 2001, 69:2390-2395.
16. Loffler B., Hussain M., Grundmeier M., Bruck M., Holzinger D., Varga G., Roth J., Kahl B.C., Proctor R.A., Peters G. Staphylococcus aureus Panton-Valentine leukocidin is a very potent cytotoxic factor for human neutrophils. PLoS Pathog 2010, 6:e100715.
17. Dumont A.L., Nygaard T.K., Watkins R.L., Smith A., Kozhaya L., Kreiswirth B.N., Shopsin B., Unutmaz D., Voyich J.M., Torres V.J. Characterization of a new cytotoxin that contributes to Staphylococcus aureus pathogenesis. Mol Microbiol 2010, 79:814-825.
18. Morinaga N., Kaihou Y., Noda M. Purification, cloning and characterization of variant LukE-LukD with strong leukocidal activity of staphylococcal bi-component leukotoxin family. Microbiol Immunol 2003, 47:81-90.
19. Malachowa N., Kobayashi S.D., Braughton K.R., Whitney A.R., Parnell M.J., Gardner D.J., Deleo F.R. Staphylococcus aureus leukotoxin GH promotes inflammation. J Infect Dis 2012, 206:1185-1193.
20. Alonzo F., Benson M.A., Chen J., Novick R.P., Shopsin B., Torres V.J. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol 2012, 83:423-435.
21. Kamio Y., Rahman A., Nariya H., Ozawa T., Izaki K. The two staphylococcal bi-component toxins, leukocidin and gamma-hemolysin, share one component in common. FEBS Lett 1993, 321:15-18.
22. Malachowa N., Whitney A.R., Kobayashi S.D., Sturdevant D.E., Kennedy A.D., Braughton K.R., Shabb D.W., Diep B.A., Chambers H.F., Otto M., et al. Global changes in Staphylococcus aureus gene expression in human blood. PLoS ONE 2011, 6:e18617.
23. Nilsson I.M., Hartford O., Foster T., Tarkowski A. Alpha-toxin and gamma-toxin jointly promote Staphylococcus aureus virulence in murine septic arthritis. Infect Immun 1999, 67:1045-1049.
24. von Eiff C., Friedrich A.W., Peters G., Becker K. Prevalence of genes encoding for members of the staphylococcal leukotoxin family among clinical isolates of Staphylococcus aureus. Diagn Microbiol Infect Dis 2004, 49:157-162.
25. Ventura C.L., Malachowa N., Hammer C.H., Nardone G.A., Robinson M.A., Kobayashi S.D., DeLeo F.R. Identification of a novel Staphylococcus aureus two-component leukotoxin using cell surface proteomics. PLoS ONE 2010, 5:e11634.
26. Lina G., Piemont Y., Godail-Gamot F., Bes M., Peter M.O., Gauduchon V., Vandenesch F., Etienne J. Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. Clin Infect Dis 1999, 29:1128-1132.
27. Sharma-Kuinkel B.K., Ahn S.H., Rude T.H., Zhang Y., Tong S.Y., Ruffin F., Genter F.C., Braughton K.R., Deleo F.R., Barriere S.L., et al. Presence of genes encoding panton-valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus. J Clin Microbiol 2012, 50:848-856.
28. Boakes E., Kearns A.M., Badiou C., Lina G., Hill R.L., Ellington M.J. Do differences in Panton-Valentine leukocidin production among international methicillin-resistant Staphylococcus aureus clones affect disease presentation and severity?. J Clin Microbiol 2012, 50:1773-1776.
29. Hamilton S.M., Bryant A.E., Carroll K.C., Lockary V., Ma Y., McIndoo E., Miller L.G., Perdreau-Remington F., Pullman J., Risi G.F., et al. In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. Clin Infect Dis 2007, 45:1550-1558.
30. Campbell S.J., Deshmukh H.S., Nelson C.L., Bae I.G., Stryjewski M.E., Federspiel J.J., Tonthat G.T., Rude T.H., Barriere S.L., Corey R., et al. Genotypic characteristics of Staphylococcus aureus isolates from a multinational trial of complicated skin and skin structure infections. J Clin Microbiol 2008, 46:678-684.
31. Bae I.G., Tonthat G.T., Stryjewski M.E., Rude T.H., Reilly L.F., Barriere S.L., Genter F.C., Corey G.R., Fowler V.G. Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial. J Clin Microbiol 2009, 47:3952-3957.
32. Lalani T., Federspiel J.J., Boucher H.W., Rude T.H., Bae I.G., Rybak M.J., Tonthat G.T., Corey G.R., Stryjewski M.E., Sakoulas G., et al. Associations between the genotypes of Staphylococcus aureus bloodstream isolates and clinical characteristics and outcomes of bacteremic patients. J Clin Microbiol 2008, 46:2890-2896.
33. Diep B.A., Chan L., Tattevin P., Kajikawa O., Martin T.R., Basuino L., Mai T.T., Marbach H., Braughton K.R., Whitney A.R., et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA 2010, 107:5587-5592.
34. Diep B.A., Palazzolo-Ballance A.M., Tattevin P., Basuino L., Braughton K.R., Whitney A.R., Chen L., Kreiswirth B.N., Otto M., DeLeo F.R., et al. Contribution of Panton-Valentine leukocidin in community-associated methicillin-resistant Staphylococcus aureus pathogenesis. PLoS ONE 2008, 3:e3198.
35. Lipinska U., Hermans K., Meulemans L., Dumitrescu O., Badiou C., Duchateau L., Haesebrouck F., Etienne J., Lina G. Panton-Valentine leukocidin does play a role in the early stage of Staphylococcus aureus skin infections: a rabbit model. PLoS ONE 2011, 6:e22864.
36. Kobayashi S.D., Malachowa N., Whitney A.R., Braughton K.R., Gardner D.J., Long D., Bubeck Wardenburg J., Schneewind O., Otto M., Deleo F.R. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis 2011, 204:937-941.
37. Olsen R.J., Kobayashi S.D., Ayeras A.A., Ashraf M., Graves S.F., Ragasa W., Humbird T., Greaver J.L., Cantu C., Swain J.L., et al. Lack of a major role of Staphylococcus aureus Panton-Valentine leukocidin in lower respiratory tract infection in nonhuman primates. Am J Pathol 2010, 176:1346-1354.
38. Konig B., Prevost G., Piemont Y., Konig W. Effects of Staphylococcus aureus leukocidins on inflammatory mediator release from human granulocytes. J Infect Dis 1994, 171:607-613.
39. 2+ channels in the membrane of human polymorphonuclear neutrophils. J Membr Biol 1998, 162:209-216.
40. Yoong P., Pier G.B. Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun 2012, 80:2894-2904.
41. Yoong P., Pier G.B. Antibody-mediated enhancement of community-acquired methicillin-resistant Staphylococcus aureus infection. Proc Natl Acad Sci USA 2010, 107:2241-2246.
42. Graves S.F., Kobayashi S.D., Braughton K.R., Whitney A.R., Sturdevant D.E., Rasmussen D.L., Kirpotina L.N., Quinn M.T., DeLeo F.R. Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J Leukoc Biol 2012, 92:361-374.
43. Perret M., Badiou C., Lina G., Burbaud S., Benito Y., Bes M., Cottin V., Couzon F., Juruj C., Dauwalder O., et al. Cross-talk between Staphylococcus aureus leukocidins-intoxicated macrophages and lung epithelial cells triggers chemokine secretion in an inflammasome-dependent manner. Cell Microbiol 2012, 14:1019-1036.
44. Munoz-Planillo R., Franchi L., Miller L.S., Nunez G. A critical role for hemolysins and bacterial lipoproteins in Staphylococcus aureus-induced activation of the Nlrp3 inflammasome. J Immunol 2009, 183:3942-3948.
45. Gurcel L., Abrami L., Girardin S., Tschopp J., van der Goot F.G. Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006, 126:1135-1145.
46. Bersbaken T.F.S., Cookson B.T. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009, 7:99-109.
47. Graves S.F., Kobayashi S.D., Braughton K.R., Diep B.A., Chambers H.F., Otto M., Deleo F.R. Relative contribution of Panton-Valentine leukocidin to PMN plasma membrane permeability and lysis caused by USA300 and USA400 culture supernatants. Microbes Infect 2010, 12:446-456.
48. Li M., Cheung G.Y., Hu J., Wang D., Joo H.S., Deleo F.R., Otto M. Comparative analysis of virulence and toxin expression of global community-associated methicillin-resistant Staphylococcus aureus strains. J Infect Dis 2010, 202:1866-1876.
49. Pietrocola G., Arciola C.R., Rindi S., Di Poto A., Missineo A., Montanaro L., Speziale P. Toll-like receptors (TLRs) in innate immune defense against Staphylococcus aureus. Int J Artif Organs 2011, 34:799-810.
50. Yoong P. Immunomodulation by the Panton-Valentine leukocidin can benefit the host during Staphylococcus aureus infections. Virulence 2013, 4:92-96.